Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial
ConclusionPatients with acute large-vessel ischemic stroke who received ticagrelor within the first 24 hours after ischemic stroke had better clinical outcomes based on recurrent stroke rates, NIHSS reduction, and favorable mRS rates compared with those who received clopidogrel. There were no differences between ticagrelor and clopidogrel regarding hemorrhagic and non-hemorrhagic complications.Trial RegistrationClinical trials.gov (NCT06120725).
Source: CNS Drugs - Category: Neurology Source Type: research
More News: African Health | Clinical Trials | Clopidogrel | Egypt Health | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Plavix | Stroke | Study